Edward C. Kuan, University of California, Irvine
Eric W. Wang, University of Pittsburgh Medical Center
Nithin D. Adappa, University of Pennsylvania Perelman School of Medicine
Daniel M. Beswick, University of California, Los Angeles
Nyall R. London, Johns Hopkins School of Medicine
Shirley Y. Su, The University of Texas MD Anderson Cancer Center
Marilene B. Wang, University of California, Los Angeles
Waleed M. Abuzeid, University of Washington
Borislav Alexiev, Northwestern University Feinberg School of Medicine
Jeremiah A. Alt, The University of Utah
Paolo Antognoni, Università degli Studi dell'Insubria
Michelle Alonso-Basanta, University of Pennsylvania Perelman School of Medicine
Pete S. Batra, Rush University Medical Center
Mihir Bhayani, Rush University Medical Center
Diana Bell, City of Hope National Med Center
Manuel Bernal-Sprekelsen, Universitat de Barcelona
Christian S. Betz, Universitätsklinikum Hamburg-Eppendorf
Jean Yves Blay, Université Claude Bernard Lyon 1
Benjamin S. Bleier, Harvard Medical School
Juliana Bonilla-Velez, University of Washington
Claudio Callejas, Pontificia Universidad Católica de Chile
Ricardo L. Carrau, The Ohio State University
Roy R. Casiano, University of Miami Leonard M. Miller School of Medicine
Paolo Castelnuovo, Università degli Studi dell'Insubria
Rakesh K. Chandra, Vanderbilt University Medical Center
Vasileios Chatzinakis, Hygeia Hospital
Simon B. Chen, Stanford University School of Medicine
Alexander G. Chiu, University of Kansas Medical Center
Stephen C. Hernandez, LSU Health Sciences Center - New OrleansFollow
et al

Document Type

Article

Publication Date

9-2-2023

Publication Title

International Forum of Allergy and Rhinology

Abstract

Background; Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology; Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field. Methods; In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses format, and completed sections underwent a thorough and iterative consensus-building process. The final document underwent rigorous synthesis and review prior to publication. Results; The ICSNT document consists of four major sections; general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology-based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention. Conclusion; As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.

PubMed ID

37658764

Volume

14

Issue

2

Comments

See article for full author list.

Download

Share

COinS